Acadia Healthcare (NASDAQ:ACHC) Sets New 1-Year Low – Should You Sell?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) hit a new 52-week low during trading on Monday . The company traded as low as $21.64 and last traded at $21.51, with a volume of 698316 shares. The stock had previously closed at $23.91.

Analysts Set New Price Targets

A number of research firms recently issued reports on ACHC. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Barclays lowered shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $43.00 to $35.00 in a research report on Friday, February 28th. Royal Bank of Canada lowered their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. TD Cowen cut their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Finally, Guggenheim initiated coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They set a “buy” rating and a $36.00 target price on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $50.39.

Acadia Healthcare Price Performance

The company has a market capitalization of $1.90 billion, a P/E ratio of 6.76, a price-to-earnings-growth ratio of 1.46 and a beta of 1.13. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The business’s 50-day moving average is $31.39 and its two-hundred day moving average is $39.67.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. Wellington Management Group LLP boosted its position in Acadia Healthcare by 0.7% during the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock valued at $465,283,000 after acquiring an additional 76,490 shares in the last quarter. FMR LLC boosted its holdings in shares of Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company’s stock worth $247,045,000 after buying an additional 4,489,681 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Acadia Healthcare by 18.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company’s stock valued at $126,189,000 after purchasing an additional 486,395 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after acquiring an additional 454,044 shares in the last quarter. Finally, Madison Avenue Partners LP purchased a new position in shares of Acadia Healthcare during the 4th quarter valued at $76,339,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.